BPCI Supply Chain Initiative Working Session | Building Ireland's Supply Chain Advantage Together
Global biopharmaceutical supply chains are actively pivoting towards regional resilience in response to heightened trade disruptions and geopolitical tensions. Join us to help shape a strategic white paper, supported by industry case studies and operational insights, that demonstrates why Ireland remains a leading location for pharmaceutical supply chain investment.
The white paper will support industry advocacy and engagement with government, regulators, policymakers, investors, and global biopharmaceutical companies, reinforcing Ireland's position as a world-class location for pharmaceutical supply chain operations.
Purpose of the Working Session
This session will highlight why Ireland remains a leading location for pharmaceutical investment, manufacturing, and supply chain operations. Through a stable regulatory framework, industry expertise, and strong cross-sector collaboration, Ireland provides a supportive environment for innovation and resilient supply chains.
Attendees will contribute their operational experience and insights to validate and strengthen the key proof points in the white paper. Their input will help ensure the paper reflects real-world supply chain challenges and opportunities, adding credibility, practical context, and industry evidence to the case for Why Ireland for Pharmaceutical Supply Chains?
Event Details
Join us to share your insights and help inform the Why Ireland for Pharmaceutical Supply Chains? white paper, which will support industry engagement with government, policymakers, regulators, investors, and global stakeholders. We look forward to welcoming you and hearing your perspective.